The Impact of Interval between Recurrence and Reinjection in Anti-VEGF Therapy for Diabetic Macular Edema in Pro Re Nata Regimen.

Yoshihiro Takamura Teruyo KidaHidetaka NomaMakoto InoueShigeo YoshidaTaiji NagaokaKousuke NodaYutaka YamadaMasakazu MoriokaMakoto GozawaTakehiro MatsumuraMasaru Inatani

Published in: Journal of clinical medicine (2021)

The prompt group was superior in anatomical and functional improvement of DME in anti-VEGF therapy than the deferred group. Our data suggests that shorter WT is recommended for better visual prognosis in the treatment for DME.

Keyphrases

vascular endothelial growth factor
endothelial cells
electronic health record
big data
stem cells
mesenchymal stem cells
combination therapy
free survival
bone marrow
deep learning
cell therapy